News

TB Misdiagnosis: Swedish Student Compelled to Take TB Drugs for a Year This is the first in our series “TB Treatment Stories,” where we meet people who have had first-hand experience taking standard tuberculosis drugs, which were developed and approved more than 40 years ago . As the Working Group...

Cofactor F420 Structure The need for the identification of novel TB drug targets and biomarkers has been highlighted in a few of our posts over the last several months. A recent epublication (online manuscript before print) in the Journal of Bacteriology by Jeremy D. Selengut and Daniel H. Haft...

This is part one of our interview, which was recorded on June 9, 2010 at the Global Tuberculosis Institute in Newark, NJ. Dr. Lee Reichman Lee B. Reichman, MD, MPH, is the Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine,...

(photo: http://www.musc.edu/chp/papem ) The route of drug delivery for TB drugs is an interesting one with the usual (and valuable) room for debate about different methods. While the standard mode of delivery for most drugs is oral, there is ongoing discussion as to whether aerosol delivery of TB...

This article originally appeared in the Hindustan Times . To read more about the stigma that women TB patients in India can face, please click here . Indian women TB patients can face stigma or even violence. Photo: John-Michael Maas / Darby Communications Eight months into her marriage, Rose...

Citizen News Service Vienna 2010: PREVENT TB: IPT works, IPT is safe Bobby Ramakant – Citizen News Service (CNS) ******************************************** In Lesotho, Isoniazid Preventive Therapy (IPT) to prevent latent TB infection from becoming active TB disease, is not available for ordinary...

TAG 2010 Pipeline Report Treatment Action Group (TAG) recently released their TAG 2010 Pipeline Report (.pdf – 1,700kb), an annual report that explores the progress and overall state of drug development in the fields of HIV, Tuberculosis, and Viral Hepatitis. The report covers the development of...

Fourth Annual New England TB Symposium On Friday, July 16 th , the fourth annual New England TB Symposium took place at the Broad Institute, in Cambridge, Massachusetts. The symposium was in collaboration with the US-Japan Cooperative Medical Sciences Program: 45 th Tuberculosis and Leprosy...

Connecting the DOTS: Unprecedented Approach to Ensure Compliance This is the fourth in our series “The Sanatorium Files.” Throughout this series we’ve taken an in-depth look at how tuberculosis has been diagnosed and treated with folk cures and sanatorium stays throughout history, and the...

Genotype MTBDRplus assay kit Last week we highlighted the Xpert® MTB/RIF assay for diagnostic testing . This week, we will briefly describe the GenoType® MTBDR plus assay . The GenoType® MTBDR plus assay uses PCR to amplify biotin-labeled amplicons (single-stranded DNA sequences) of M. tb from...

This story was published on NDTV.com http://origin-netmg.ndtv.com/article/india/the-outcasts-of-tb-tuberculosis-36625 It may be curable but Tuberculosis (TB) remains a stigma in our country especially for women. Over a lakh Indian women are thrown out of their homes each year because they have TB...

This post originally appeared on Voices of America news.com http://www1.voanews.com/english/news/health/Dual-Infections-Of-TB-And-AIDS-Make-Each-Harder-To-Treat-97817769.html TB patient in Lesotho Tuberculosis infects nearly ten million people each year and kills nearly two million. It is primarily...

Rest and Fresh Air: The Sanatorium Movement This is the third installment in our series “The Sanatorium Files.” Photo of patients 'resting' at a sanatorium Without the scientific understanding needed to develop effective therapeutics to fight tuberculosis in its many forms, doctors, patients,...

Cepheid® MTB/RIF Assay cartridge In our latest ‘Sanatorium Files’ post ‘Diagnosis Dilemma’ , we commented on the current advances in TB diagnostics. We’re following up on this theme for the next couple of posts to share the scientific data supporting some of the most promising of these new...

TB Alliance and DNDi Enter into a Unique Collaboration New Potential TB Drugs to be Investigated Against Multiple Neglected Diseases A Unique Collaboration: TB Alliance and DND i Enter Cross-Disease License Agreement to Speed Development of Novel Therapies New York, United States and Geneva,...